SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: DALTS who wrote (9644)7/3/1998 4:03:00 PM
From: Findit  Read Replies (1) | Respond to of 14328
 
Dalts I only included guesses that fit the potential of Triby. Triby won't be around by 2001. Made no sense to record such a guess. VBG

The Judge




To: DALTS who wrote (9644)7/3/1998 11:27:00 PM
From: Scott H. Davis  Read Replies (1) | Respond to of 14328
 
Being neither a TRIBY bull nor bear at this point, but having done a lot of analysis on this investment, in my opinion, TRIBY does stand a very good chance of hitting $3.00 next year IF:

Revenues keep increasing. The effect of lower cost structure and spreading overhead over more sales would be very positive, and contribute to a growing EPS

IF

TRIBY management cools it in terms of issuing paper - I know the recent comments about management intent, but based on past history, we won't know if they've changed their ways until several qtrs out.

This includes granting themselves more options.

Otherwise, returns will be limited. Scott